Site logo
Site logo
Site logo
  • Learn
    • COVID-19
    • Congressional Biomedical Research Caucus Briefings
      • Caucus Briefing Calendar
      • About the CBRC
      • Caucus Members
    • Facilities and Administrative Costs: What Scientists Need to Know
    • News & Updates
    • Events
    • Research Funding Facts
    • Congressional Testimony
    • Beyond 2020: A Vision and Pathway for NIH Report
  • Advocate
    • Support Pro-Science Candidates in National, State, and Local Elections
    • Take Action
    • Advocacy Tips
      • An Introduction to Science Public Policy
      • Ideas for Advocacy
      • Presentation Best Practices
      • Communicating with Congress
        • NIH and NSF Talking Points
      • Communicating with the Media
        • Writing a Letter to the Editor
      • Finding Community Allies
    • Be An Advocate
    • Rally for Medical Research
    • Letters to Congress
  • About CLS
    • About Us
    • Director
    • Board of Directors
    • CLS History
    • Member Organizations
  • Contact Us
  • Donate

Letters to Congress

CBRC Briefing Zika Virus: What Is It and Can We Stop It?
April 15, 2016

Zika Virus: What Is It and Can We Stop It?

Join the Congressional Biomedical Research Caucus as Dr. Weaver, a nationally distinguished virologist, explains what the Zika virus is. Dr. Weaver will discuss the outbreaks caused by this mosquito-borne virus

CBRC Briefing How to Make New Drugs? Start with Basic Research!
March 23, 2016

How to Make New Drugs? Start with Basic Research!

Dr. Mark Fishman of the Novartis Institutes for Biomedical Research, discusses several current programs in drug discovery that promise to change the practice of medicine. Each grew from basic science

Testimony The Important and Lifesaving Research Being Done with Fetal Cells and Fetal Tissue
March 2, 2016

The Important and Lifesaving Research Being Done with Fetal Cells and Fetal Tissue

Statement of Lawrence Goldstein, Ph.D. Distinguished Professor, Dept. of Cellular and Molecular Medicine, Dept. of Neurosciences Director, UC San Diego Stem Cell Program Scientific Director, Sanford Consortium for Regenerative Medicine

CBRC Briefing Chromothripsis and the Legacy of Henrietta Lacks
September 16, 2015

Chromothripsis and the Legacy of Henrietta Lacks

One of the features of many cancers is the loss of genome integrity. One of the most stunning examples of this is chromothripsis. Chromothripsis involves the shuffling or rearrangement of

News and Updates Congressional Biomedical Research Caucus Briefing
September 11, 2015

Congressional Biomedical Research Caucus Briefing

One of the features of many cancers is the loss of genome integrity. One of the most stunning examples of this is chromothripsis. Chromothripsis involves the shuffling or rearrangement of

CBRC Briefing Can Cells Return from the Brink of Death?
July 29, 2015

Can Cells Return from the Brink of Death?

Scientific dogma for decades has dictated that once a cell dies it cannot be resurrected. Dr. Denise Montell discusses her groundbreaking discovery that overturns this widely held belief. What she

News and Updates Unlocking the Cures for America’s Most Deadly Diseases
July 16, 2015

Unlocking the Cures for America’s Most Deadly Diseases

Dr. Keith R. Yamamoto, Vice Chancellor for Research, UCSF Executive Vice Dean, School of Medicine Professor, Cellular & Molecular Pharmacology July 14, 2015 Testimony for the Record for the Subcommittee

Testimony Unlocking the Cures for America’s Most Deadly Diseases
July 14, 2015

Unlocking the Cures for America’s Most Deadly Diseases

"Unlocking the Cures for America’s Most Deadly Diseases”

Prev

Posts navigation

  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 21
Next
Image module

6120 Executive Blvd.,
Suite 750
Rockville, MD 20852
T 301 347.9309
F 301 347.9310

CLS Member Organizations

Image module
Image module
Image module
Image module
Image module
Image module
Image module
Image module
Image module
div#stuning-header .dfd-stuning-header-bg-container {background-color: #0067ac;background-size: cover;background-position: center center;background-attachment: scroll;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 260px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}